Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Broad sarbecovirus neutralization by a human monoclonal antibody
Nature, settembre 2021

2) Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Nature, luglio 2020

3) Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Journal of Hepatology, 17 luglio 2023

4) Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
iScience, 20 gennaio 2023

5) Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
PLoS One, 10 febbraio 2022

6) Broad betacoronavirus neutralization by a stem helix-specific human antibody
Science, 3 settembre 2021

7) Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Nature, 31 agosto 2021

8) Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges
Frontiers in Immunology, 3 agosto 2021

9) SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Nature, 14 luglio 2021

10) SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Science, 1 luglio 2021

11) Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Cell Reports, 29 giugno 2021

12) Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
The Lancet Regional Health - Europe, febbraio 2021

13) N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Cell, 16 marzo 2021

14) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature, 11 marzo 2021

15) SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
medRxiv, 15 febbraio 2021

16) Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Cell, 28 gennaio 2021

17) Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
Science, 20 novembre 2020

18) Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Cell, https://www.cell.com/cell/fulltext/S0092-8674(20)31234-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420312344%3Fshowall%3Dtrue